Patents by Inventor Hans van Dijk

Hans van Dijk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090162357
    Abstract: Complement is recognized as an important, humoral defense system involved in the innate (nonspecific) recognition and elimination of microbial invaders, other foreign particles or molecules, and antigen-antibody complexes from the body. The present invention makes use of the surprising notion that the handling of lipids by the body, rather than its antimicrobial activity, is the primary and most ancient function of the complement system. Consequently, atherosclerosis as observed in disorders associated with disturbed lipid metabolism (familial combined hyperlipidemia (FCHL), postprandial hyperlipidemia, hypertriglyceridemia with low levels of HDL cholesterol, and insulin resistance associated with type-II diabetes and obesity), is ascribed to either genetic or acquired defects in ancient (activatory and/or regulatory) complement components. Based on this new insight, novel preventive measures and treatment modalities of disturbed lipid metabolism are introduced.
    Type: Application
    Filed: June 25, 2008
    Publication date: June 25, 2009
    Inventors: Manuel Castro Cabezas, Hans van Dijk, Petronella Maria van
  • Patent number: 7498147
    Abstract: Complement is recognized as an important, humoral defense system involved in the innate (nonspecific) recognition and elimination of microbial invaders, other foreign particles or molecules, and antigen-antibody complexes from the body. The present invention makes use of the surprising notion that the handling of lipids by the body, rather than its antimicrobial activity, is the primary and most ancient function of the complement system. Consequently, atherosclerosis as observed in disorders associated with disturbed lipid metabolism (familial combined hyperlipemia (FCHL), postprandial hyperlipidemia, hypertriglyceridemia with low levels of HDL cholesterol, and insulin resistance associated with type-II diabetes and obesity), is ascribed to either genetic or acquired defects in ancient (activatory and/or regulatory) complement components. Based on this new insight, novel preventive measures and treatment modalities of disturbed lipid metabolism are introduced.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: March 3, 2009
    Assignee: Crossbeta Biosciences B.V.
    Inventors: Manuel Castro Cabezas, Hans van Dijk
  • Publication number: 20050027061
    Abstract: The invention relates to a thermosetting resin composition including a radically curable resin mixture of: a) 50-100 parts by weight of a radically curable resin that also contains a free monomer capable of copolymerising with it; b) 0-50 parts by weight of a shrink-resistant compound that can also contain an amount of copolymerisable free monomer, the total of (a) and (b) adding up to 100, and 2D-randomly distributed, discontinuous carbon fibres obtained by chopping split, continuous carbon fibre bundles to form packages of carbon filaments, which carbon bundles are provided with a sizing that is at least partially chemically bonded thereto, and with a binder whose solubility at room temperature in the copolymerisable free monomer present in the radically curable resin mixture amounts to at least 10% by weight, the weight percentage of carbon fibres relative to the resin composition being between 5 and 65% by weight, and optionally a filler also being present.
    Type: Application
    Filed: January 21, 2004
    Publication date: February 3, 2005
    Inventors: Hans Van Dijk, Gerardus Janse, Hans Hornman, Antonius Van Der Ploeg
  • Publication number: 20030165458
    Abstract: Complement is recognized as an important, humoral defense system involved in the innate (nonspecific) recognition and elimination of microbial invaders, other foreign particles or molecules, and antigen-antibody complexes from the body. The present invention makes use of the surprising notion that the handling of lipids by the body, rather than its antimicrobial activity, is the primary and most ancient function of the complement system. Consequently, atherosclerosis as observed in disorders associated with disturbed lipid metabolism must be ascribed to either genetic or acquired defects in ancient (activatory and/or regulatory) complement components. The surprising notion is of considerable consequence to the treatment of diseases of the immune system and/or an infectious, autoimmune, neoplastic and/or hematological disease related to complement-mediated lipid metabolism and/or an underlying and/or related disease since lipids and immune complexes share the same transport pathway in the human body.
    Type: Application
    Filed: December 20, 2002
    Publication date: September 4, 2003
    Inventors: Manuel Castro Cabezas, Hans van Dijk
  • Publication number: 20030143223
    Abstract: Complement is recognized as an important, humoral defense system involved in the innate (nonspecific) recognition and elimination of microbial invaders, other foreign particles or molecules, and antigen-antibody complexes from the body. The present invention makes use of the surprising notion that the handling of lipids by the body, rather than its antimicrobial activity, is the primary and most ancient function of the complement system. Consequently, atherosclerosis as observed in disorders associated with disturbed lipid metabolism (familial combined hyperlipemia (FCHL), postprandial hyperlipidemia, hypertriglyceridemia with low levels of HDL cholesterol, and insulin resistance associated with type-II diabetes and obesity), is ascribed to either genetic or acquired defects in ancient (activatory and/or regulatory) complement components. Based on this new insight, novel preventive measures and treatment modalities of disturbed lipid metabolism are introduced.
    Type: Application
    Filed: December 20, 2002
    Publication date: July 31, 2003
    Inventors: Manuel Castro Cabezas, Hans van Dijk